Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Research Article

The Gottfries-Bråne-Steen Scale: Validity, Reliability and Application in Anti-Dementia Drug Trials

Bråne G.a · Gottfries C.G.a · Winblad B.b

Author affiliations

aInstitute of Clinical Neuroscience, Department of Psychiatry and Neurochemistry, Sahlgrenska University Hospital, Mölndal, and bKarolinska Institute, Department of Clinical Neuroscience, Occupational Therapy and Elderly Care Research, Division of Geriatric Medicine, Huddinge Hospital B, Huddinge, Sweden

Related Articles for ""

Dement Geriatr Cogn Disord 2001;12:1–14

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Published online: December 15, 2000
Issue release date: January – February

Number of Print Pages: 14
Number of Figures: 2
Number of Tables: 4

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Abstract

Neuropsychological investigation using a comprehensive rating scale is important for the diagnosis and evaluation of dementia patients over time. Requirements for such a scale include accuracy, reliability, sensitivity of the scale over the disease course and simplicity for clinical use by a wide range of healthcare professionals. Ideally, the scale should also be capable of assessing the impact of pharmacological and non-pharmacological treatment regimens on the management of dementia patients. The Gottfries-Bråne-Steen (GBS) Scale is a comprehensive global assessment tool for evaluating dementia symptoms and is based on a semi-structured interview and observation of the patient. The scale consists of subscales measuring intellectual (12 items), emotional (3 items) and activities of daily living, primarily items of self-care (6 items); as well as 6 items of behavioral and psychological symptoms of dementia. This review describes the reliability, validity and sensitivity of the most recent version of the GBS scale since its original publication in 1982.

© 2001 S. Karger AG, Basel


References

  1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. American Psychiatric Association, Washington, 1994.
  2. Lezak M: Neuropsychological Assessment, ed 3. Oxford, Oxford University Press, 1995.
  3. Kolb B, Whishaw IQ: Fundamentals of Human Neuropsychology, ed 4. New York, Freeman, 1996.
  4. Dencker K, Gottfries CG: The closure of a mental hospital in Sweden: Characteristics of patients in long-term care facing relocation into the community. Eur Arch Psychiatry Clin Neurosci 1991;240:325–330.
  5. Sjobeck B, Isacsson A: Caring for demented elderly in rural primary health care. Scand J Caring Sci 1994;8:29–37.
  6. Sjögren M, Wallin A, Edman Å: Symptomatological characteristics distinguish between frontotemporal dementia and vascular dementia with a dominant frontal lobe syndrome. Int J Geriatr Psychiatry 1997;12:656–661.
  7. McGlynn SM, Kaszniak AW: When metacognition fails: Impaired awareness of deficit in Alzheimer’s disease. J Cognitive Neurosci 1991;3:183–189.
  8. Almqvist O, Bråne G, Johanson A: Neuropsychological assessment of dementia: State of the art. Acta Neurol Scand 1996;168(suppl):45–49.
  9. Gottfries CG, Bråne G, Gullberg B, Steen G: A new rating scale for dementia syndromes. Arch Gerontol Geriatr 1982;1:311–330.
  10. Åsberg M, Montgomery SA, Perris C, Schalling D, Sedvall G: A comprehensive psychopathological rating scale. Acta Psychiatr Scand 1978;271:5–27.
  11. Shader RI, Harmatz JS, Salzman C: A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment-Geriatric (SCAG). J Am Geriatr Soc 1974;22:107–113.
    External Resources
  12. Adolfsson R, Gottfries CG, Nyström L, Winblad B: Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. Acta Psychiatr Scand 1981;63:245–252.
    External Resources
  13. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  14. Hamilton M: Development of a rating scale for primary depressive illness. Br J Social Clin Psychol 1967;6:278–296.
  15. Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH: Validity and reliability of the Alzheimer’s Disease Cooperative Study – Clinical Global Impression of Change. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997;11(suppl 2):S22–S32.
  16. Marcusson J, Rother M, Kittner B, Rossner M, Smith RJ, Babic T, Folnegovic-Smalc V, Moller HJ, Labs KH: A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. Dement Geriatr Cogn Disord 1997;8:320–328.
    External Resources
  17. Parnetti L, Ambrosoli L, Agliati G, Caratozzolo P, Fossati L, Frattola L, Martucci N, Murri L, Nappi G, Puca FM, Poli A, Girardello R, Senin U: Posatirelin in the treatment of vascular dementia: A double-blind multicentre study vs placebo. Acta Neurol Scand 1996;93:456–463.
  18. European Pentoxifylline Multi-Infarct Dementia Study. Eur Neurol 1996;36:315–321.
  19. Dehlin O, Hedenrud B, Jansson P, Nörgård J: A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. Acta Psychiatr Scand 1985;71:190–196.
    External Resources
  20. Urakami K, Shimomura T, Ohshima T, Okada A, Adachi Y, Takahashi K, Asakura M, Matsumura R: Clinical effect of WEB 1881 (nebracetam fumarate) on patients with dementia of the Alzheimer type and study of its clinical pharmacology. Clin Neuropharmacol 1993;16:347–358.
  21. Saletu B, Moller H-J, Grunberger J, Deutsch H, Rossner M: Propentofylline in adult-onset cognitive disorders: Double-blind, placebo-controlled, clinical, psychometric and brain mapping studies. Neuropsychobiology 1990–91;24:173–184.
  22. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N: Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 1995;6:99–107.
  23. Möller HJ, Maurer K, Saletu B: Placebo-controlled trial of the xanthine derivative propentofylline in dementia. Pharmacopsychiatry 1994;27:159–165.
    External Resources
  24. Görtelmeyer R, Erbler H: Memantine in the treatment of mild to moderate dementia syndrome. Arzneimittelforschung 1992;42:904–913.
  25. Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M, Refsum HE, Ofsti E, Eriksson S, Syversen S: A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 1992;86:138–145.
  26. Ragneskog H, Eriksson S, Karlsson I, Gottfries C-G: Long-term treatment of elderly individuals with emotional disturbances: An open study with citalopram. Int Psychogeriatr 1996;8:659–668.
  27. Augustinsson LE, Blennow K, Blomstrand C, Bråne G, Ekman R, Fredman P, Karlsson I, Kihlgren M, Lehman W, Lekman A, Månsson JE, Ramström I, Wallin A, Wikkelsö C, Gottfries C-G, Svennerholm L: Intracerebroventricular administration of GM1 ganglioside to presenile Alzheimer patients. Dement Geriatr Cogn Disord 1997;8:26–33.
    External Resources
  28. Robertsson B, Wallin A, Nyth AL, Gottfries CG, Blennow K: Lack of efficacy of vinpocetine in vascular dementia. Dementia 1990;1:316–322.
  29. Heinonen EH, Savijarvi M, Kotila M, Hajba A, Scheinin M: Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer’s disease. J Neural Transm 1993;5:193–202.
  30. Anderson M: Elderly patients in nursing homes and in home care: Scope of institutional care, characteristics, motor and intellectual functions, drug consumption and quality of life; thesis, University of Gothenburg, 1989.
  31. Bråne G: Normal aging and dementia disorders – Coping and crisis in the family. Prog Neuropsychopharmacol Biol Psychiatry 1986;10:287–294.
  32. Koponen H, Stenbäck U, Mattila E, Soininen H, Reinikainen K, Riekkinen PJ: Delirium among elderly persons admitted to a psychiatric hospital: Clinical course during the acute stage and one-year follow-up. Acta Psychiatr Scand 1989;79:579–585.
    External Resources
  33. Ragneskog H, Bråne G, Karlsson I, Kihlgren M: Influence of dinner music on food intake and symptoms common in dementia. Scan J Caring Sci 1996;10:11–17.
  34. Karlsson I, Bråne G, Melin E, Nyth AL, Rybo E: Effects of environmental stimulation on biochemical and psychological variables in dementia. Acta Psychiatr Scand 1988;77:207–213.
    External Resources
  35. Palo-Bengtsson L, Winblad B, Ekman SL: Social dancing a way to support intellectual, emotional and motor functions in persons with dementia. J Psychiatr Ment Health Nurs 1998;5:545–554.
  36. Nyth AL, Bråne G: Principal component analysis of the GBS scale. Dementia 1992;3:193–199.
  37. Nyth AL, Gottfries C-G, Blennow K, Bråne G, Wallin A: Heterogeneity of the course of Alzheimer’s disease: A differentiation of subgroups. Dementia 1991;2:18–24.
  38. Nyth AL: A study of the courses of Alzheimer’s disease and vascular dementia;thesis (No. 38), University of Göteborg, Mölndal, pp 1–20.
  39. Bråne G, Karlsson I: The dementia process as measured by the GBS scale. Lecture at the 15th International Conference of Alzheimer`s Disease International, Johannesburg, 15–18th September, 1999.
  40. Vega Garcia E, Bråne G, Langstrom G, Veloz T, Romero Aladro I, Perez L, Danauy Q: Estudio de confiabilidad de la version en espanol de la escala GBS para la evaluacion de la dementia. Rev Exp Geriatr Gerontol 1993;28:271–274.
  41. Streiner DL, Norman GR: Health Mesaurement scales. A Practical Guide to Their Development and Use. Oxford, Oxford University Press, 1989.
  42. Bråne G: The GBS scale – A geriatric rating scale and its clinical application; thesis (No 32), Göteborg University, 1989.
  43. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 1963;185:914–919.
  44. Dencker K, Gottfries CG: Activities of daily living ratings of elderly people using Katz’ ADL Index and the GBS-M scale. Scand J Caring Sci 1995;9:35–40.
  45. Bråne G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A: Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer’s dementia. Alzheimer Dis Assoc Disord 1989;3:148–156.
  46. Bråne G, Karlsson I, Kihlgren M, Norberg A; Diagnosis of dementia in patients in long-term somatic care. Dementia 1992, pp 205–208.
  47. Karlsson I, Bråne G, Melin E, Nyth AL, Rybo E: Effects of environmental stimulation on biochemical and psychological variables in dementia. Acta Psychiatr Scand 1988;77:207–213.
    External Resources
  48. Bråne G, Karlsson I, Kihlgren M, Norberg A: Integrity-promoting care of demented nursing home patients: Psychological and biochemical changes. Int J Geriatr Psychiatry 1989;4:165–172.
  49. Dehlin O, Franzén M: Prevalence of dementia syndromes in persons living in homes for the elderly and in nursing homes in southern Sweden. Scand J Prim Health Care 1985;3:215–222.
    External Resources
  50. Andersson M, Gottfries CG, Tomsic E: The home care patient. A comparison with the nursing home patient. Compr Gerontol 1989;3(suppl A+B):39–50.
  51. Cummings JL, Mega MS, Grey K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.
  52. Skausig OB, Kofoed K, Bråne G: Functional levels in nursing homes residents assessed by the Gottfries-Bråne-Steen scale. Ugeskr Laeger 1989;151:387–389.
    External Resources
  53. Skausig OB, Kofoed K, Bråne G: Placing of patients with dementia in nursing homes as evaluated by the Gottfries-Bråne-Steen scale. Ugeskr Laeger 1989;151:389–390.
    External Resources
  54. Balldin J, Blennow K, Bråne G, Gottfries CG, Karlsson I, Regland B, Wallin A: Relationship between mental impairment and HPA axis activity in dementia disorders. Dementia 1994;5:252–256.
  55. Smolikova J, Jirak R, Smolik P, Gottfries CG: Reliability of the Czech version of the GBS rating scale for dementia syndromes. Cesk Psychiatr 1992;88:18–25.
  56. Skausig OB, Kofoed K, Bråne G: The reliability of the Danish translation of the Gottfries-Bråne-Steen scale. Ugeskr Laeger 1989;151:1681–1683.
    External Resources
  57. Parnetti L, Ambrosoli L, Agliati G, Caratozzolo P, Fossati L, Frattola L, Martucci N, Murri L, Nappi G, Puca FM, Poli A, Girardello R, Parnetti L, Gottfries CG, Bråne G, et al: La scala GBS per la valutazione delle demenze. Un studio della inter-rater reliability della versione italiana. Giorn Geront 1989;37:293–304.
  58. Arai H, Noguchi I, Iwamoto N, Fumimoto H, Miyashita K, Iizuka R, Bråne G, Gottfries, CG: Japanese version of the GBS-Scale and its reliability. Tokyo, Juntendo University School of Medicine, 1989.
  59. Homma A, Niina R, Ishii T, Hasegawa K: Behavioral evaluation of Alzheimer disease in clinical trials: Development of the Japanese version of the GBS Scale. Alzheimer Dis Assoc Disord 1991;5:S40–S48.
    External Resources
  60. Nygaard HA, Bråne G: A new rating scale for senile dementia. Tidsskr Nor Laegeforen 1987;107:546–547.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Published online: December 15, 2000
Issue release date: January – February

Number of Print Pages: 14
Number of Figures: 2
Number of Tables: 4

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.